Loading clinical trials...

COMPLETEDNA

D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management

NCT00328705•Medtronic Cardiac Rhythm and Heart Failure

Summary

This is an acute, prospective, multi-center, non-randomized, investigational device exemption (IDE) clinical study.

Detailed Description

The purpose of this study is to confirm the performance of new sensing circuitry, and to confirm the performance of a Ventricular Capture Management feature in subjects with implantable cardioverter defibrillator (ICD) leads connected to an external pacemaker/defibrillator.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients who are scheduled for implantation or replacement of an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) device
•Patients must have or receive Medtronic transvenous atrial and ventricular leads in association with the scheduled device implant or replacement.

Exclusion Criteria

•Patients who have 3rd degree heart block, as assessed by the investigator
•Patients who have a mechanical tricuspid heart valve
•Patients who have received an investigational new drug or device, or are currently enrolled in a clinical study for a new indication of an approved drug or device

Locations (5)

Tampa, Florida, United States

Coon Rapids, Minnesota, United States

Rochester, Minnesota, United States

Saint Paul, Minnesota, United States

Charlotte, North Carolina, United States

Key Dates

Start Date

May 1, 2006

Primary Completion Date

January 1, 2007

Completion Date

January 1, 2007

Last Updated

February 13, 2008

Enrollment

ACTUAL participants

Conditions

Heart Diseases

Interventions

Implantable Cardioverter Defibrillator

DEVICE

Lumason® Infusion vs. Bolus Administrations

NCT06400004

Heart Diseases

View study

RECRUITINGNA

Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease

NCT06788275

Percutaneous Coronary Intervention (PCI)Acute Myocardial Infarction+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 13, 2008Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management

Inclusion Criteria

Exclusion Criteria

Lumason® Infusion vs. Bolus Administrations

Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease

Abbott Structural Heart Device Registry

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Use of Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Failure in the Emergency Department

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR